(NASDAQ:MRTN), MONDOVI, Wis., Aug. 19, 2025 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that Timothy Kohl, the Company's Chief Executive Officer, has decided to retire from his role as Chief Executive Officer effective September 30, 2025. Randolph Marten, the Company's Executive Chairman of the Board of Directors and previous Chief Executive Officer, has […]

(NASDAQ:CLDX), Study met primary endpoint demonstrating barzolvolimab's ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver in EoE Favorable safety profile demonstrated for barzolvolimab 300 mg Q4 weekly dosing regimen Company to

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) GlobeNewswire August 19, 2025 Study met primary endpoint demonstrating barzolvolimab's ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver

MARTEN TRANSPORT ANNOUNCES CEO RETIREMENT AND LEADERSHIP TRANSITION GlobeNewswire August 19, 2025 MONDOVI, Wis., Aug. 19, 2025 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that Timothy Kohl, the Company's Chief Executive Officer, has decided to retire from his role as Chief Executive Officer effective September 30, 2025. Randolph Marten, the Company's Executive Chairman

(NASDAQ:TRST), GLENVILLE, N.Y., Aug. 19, 2025 (GLOBE NEWSWIRE) — The Board of Directors of TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) on August 19, 2025 declared an increased quarterly cash dividend of $0.38 per share, or $1.52 per share on an annualized basis. The declared dividend represents an increase of 5.6% over the prior dividend

(NASDAQ:CYTK), SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of common stock and 70,879 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 46

(NasdaqGM:LGND), JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences: Citi 20th Annual BioPharma Conference (Boston): Management will participate in a fireside chat on September 3, 2025 at 11:15

(NASDAQ:ARQT), WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in three upcoming investor conferences. Details for the company's participation are as follows: Citi's 2025 Biopharma Back to School Conference, September 2-3,

(TSX-V:NET-UN),(TSX-V:NET-UN.V), MONTRÉAL, Aug. 19, 2025 (GLOBE NEWSWIRE) — Canadian Net Real Estate Investment Trust (“Canadian Net” or the “REIT”) (TSX-V: NET.UN) today reported its results for the quarter ended June 30th, 2025 (“Q2 2025”) and distributions for October, November and December 2025. “We are pleased with our second quarter results, highlighted by an 8% year-to-date

(NASDAQ:AAPL), NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Apple Inc. (“Apple” or “the Company”) (NASDAQ: AAPL) and certain of its officers. Class Definition This lawsuit seeks to recover damages against